What 1 hospital in Alaska charged and were paid for a Medicare hospital stay for chemotherapy without acute leukemia as secondary diagnosis with complications (DRG 847), from 2024 Medicare claims.
Hospitals in Alaska billed an average of $31,261 for chemotherapy without acute leukemia as secondary diagnosis with complications, about 2.3 times the average total payment of $13,414. That payment is 16% below the U.S. average of $16,023.
These are averages for patients with original (fee-for-service) Medicare. Private insurance pays different, negotiated prices, and what you owe depends on your plan's deductible and coinsurance. Use these figures to compare hospitals, not as a quote.
About 43¢ was paid for every $1 hospitals in Alaska billed for this stay.
Medicare prices this stay in 2 versions, by how sick the patient was. Compare them in Alaska:
Every Alaska hospital that billed Medicare for this stay at least 11 times. Click a column to sort.
| Hospital | Stays | Avg charge | Avg payment | Medicare paid |
|---|---|---|---|---|
| Providence Alaska Medical CtrAnchorage | 12 | $31,261 | $13,414 | $9,412 |
In 2024 Medicare data, a hospital stay for chemotherapy without acute leukemia as secondary diagnosis with complications (DRG 847) at 1 hospital in Alaska was billed at $31,261 on average, while the average total payment was $13,414, of which Medicare paid $9,412. Your own cost depends on your insurance, deductible and the hospital.
Charges are a hospital's list prices. Medicare pays fixed rates set in advance, and private insurers negotiate their own discounts, so almost nobody pays the full charge. For this stay in Alaska, average charges were 2.3 times the average payment. Uninsured patients can ask the hospital about its financial assistance (charity care) policy and cash prices.
Source: CMS, Medicare Inpatient Hospitals by Provider and Service, 2024. Average total payment includes Medicare's payment, the patient's deductible and coinsurance, and any other payer. CMS omits hospitals with fewer than 11 hospital stays for privacy. About the data.